DrugBiological
Interleukin-23 clinical trials
Also written Interleukin 23.
Keep track of what changes. Save the Interleukin-23 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
University of Maryland, Baltimore (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1) · Sohag University (1)
Related medicines
As reviewed, each with the page that says it.
- One of Angiogenesis Inhibitors source
Studies
Open first, then newest update. How each study uses Interleukin-23 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With SchizophreniaNot yet recruitingPhase 4University of Maryland, BaltimoreNCT07615075Written as IL-23
- Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and SafetyRecruitingPhase 4Sixth Affiliated Hospital, Sun Yat-sen UniversityNCT07216014Written as Interleukin 23
- Interleukin23 in Systemic LupusRecruitingNot applicableSohag UniversityNCT06713187Written as interleukin 23
As the comparator · 1 — what is tested is compared with Interleukin-23
Codes
What other systems call Interleukin-23 · ClinicalTrials.gg INT008893
- MeSH (NLM) D053759Interleukin-23One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D053759 | Interleukin-23 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.